ADTRAN Holdings, Inc. Stock Compensation Disclosure
Note 3 – Stock-Based Compensation
2024 Stock Incentive Plans
At the annual meeting of stockholders held on May 8, 2024, the Company’s stockholders approved, upon recommendation of the Board of Directors, the adoption of the ADTRAN Holdings, Inc. 2024 Employee Stock Incentive Plan (“2024 Employee Plan”) and the ADTRAN Holdings, Inc. 2024 Directors Stock Plan (“2024 Directors Plan”). No additional awards may be granted under the Company’s previous stock incentive plans, including the 2020 Employee Stock Incentive Plan, the 2020 Directors Stock Plan, or the 2015 Employee Stock Incentive Plan. Outstanding awards granted under the Company's prior equity incentive plans will remain subject to the terms of such applicable plans, and shares under such plans that are cancelled or forfeited will be available for issuance under the 2024 Employee Plan or the 2024 Directors Plan, as applicable.
Under the 2024 Employee Plan, the Company is authorized to issue 4.0 million shares of common stock to certain employees, key service providers and advisors through incentive stock options, non-qualified stock options, stock appreciation rights, RSUs and restricted stock, any of which may be subject to performance-based conditions. RSUs and restricted stock granted under the 2024 Employee Plan will typically vest pursuant to a four-year vesting schedule beginning on the first anniversary of the grant date. Stock options granted under the 2024 Employee Plan will typically become exercisable beginning after one year of continued employment, normally pursuant to a four-year vesting schedule beginning on the first anniversary of the grant date and have a ten-year contractual term. Stock options, RSUs and restricted stock granted under the 2024 Employee Plan reduce the shares authorized for issuance under the 2024 Employee Plan by one share of common stock for each share underlying the award. Forfeitures, cancellations and expirations of awards granted under the prior employee stock incentive plans increase the shares authorized for issuance under the 2024 Employee Plan by one share of common stock for each share underlying the award.
Under the 2024 Directors Plan, the Company is authorized to issue 0.7 million shares of common stock through stock options, restricted stock and RSUs to non-employee directors. Stock awards issued under the 2024 Directors Plan typically will become vested in full on the first anniversary of the grant date. Stock options issued under the 2024 Directors Plan will have a ten-year contractual term. Stock options, restricted stock and RSUs granted under the 2024 Directors Plan reduce the shares authorized for issuance under the 2024 Directors Plan by one share of common stock for each share underlying the award. Forfeitures, cancellations and expirations of awards granted under the prior directors stock plan increase the shares authorized for issuance under the 2024 Directors Plan by one share of common stock for each share underlying the award.
As of December 31, 2025, 4.7 million shares were available for issuance pursuant to awards that may be made in the future under stockholder-approved equity plans.
For the years ended December 31, 2025, 2024 and 2023, stock-based compensation expense was $10.1 million, $16.0 million and $16.4 million respectively.
The following table summarizes stock-based compensation expense related to stock options, PSUs, RSUs and restricted stock for the years ended December 31, 2025, 2024 and 2023:
(In thousands) |
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Stock-based compensation expense included in cost of revenue |
|
$ |
986 |
|
|
$ |
1,142 |
|
|
$ |
1,293 |
|
Selling, general and administrative expenses |
|
|
5,971 |
|
|
|
11,058 |
|
|
|
11,066 |
|
Research and development expenses |
|
|
3,105 |
|
|
|
3,788 |
|
|
|
4,022 |
|
Stock-based compensation expense included in operating expenses |
|
|
9,076 |
|
|
|
14,846 |
|
|
|
15,088 |
|
Total stock-based compensation expense |
|
|
10,062 |
|
|
|
15,988 |
|
|
|
16,381 |
|
Tax benefit for expense associated with stock based compensation |
|
|
(1,267 |
) |
|
|
(1,976 |
) |
|
|
(3,837 |
) |
Total stock-based compensation expense, net of tax |
|
$ |
8,795 |
|
|
$ |
14,012 |
|
|
$ |
12,544 |
|
PSUs, RSUs and Restricted stock
The following table summarizes the activity related to our PSUs, RSUs and restricted stock for the year ended December 31, 2025:
|
|
Number of |
|
|
Weighted |
|
||
Unvested PSUs, RSUs and restricted stock outstanding, December 31, 2024 |
|
|
2,335 |
|
|
$ |
13.22 |
|
PSUs, RSUs and restricted stock granted |
|
|
1,308 |
|
|
$ |
10.33 |
|
PSUs, RSUs and restricted stock vested |
|
|
(572 |
) |
|
$ |
12.70 |
|
PSUs, RSUs and restricted stock forfeited |
|
|
(1,104 |
) |
|
$ |
13.87 |
|
Unvested PSUs, RSUs and restricted stock outstanding, December 31, 2025 |
|
|
1,967 |
|
|
$ |
10.70 |
|
The fair value of PSUs with performance conditions, RSUs and restricted stock is equal to the closing price of the Company's stock on the date of grant. The fair value of PSUs with market conditions is calculated using a Monte Carlo simulation valuation method.
The following table details the significant assumptions that impact the fair value estimate of the market-based PSUs:
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Estimated fair value per share |
|
$ |
12.32 |
|
|
$ |
8.29 |
|
|
$ |
19.26 |
|
Expected volatility |
|
|
55.09 |
% |
|
|
51.34 |
% |
|
|
51.52 |
% |
Risk-free interest rate |
|
|
4.22 |
% |
|
|
4.12 |
% |
|
|
3.93 |
% |
Expected dividend yield |
|
|
— |
|
|
|
— |
|
|
|
2.55 |
% |
For market-based PSUs, the number of shares of common stock earned by a recipient is subject to a market condition based on Adtran’s relative total stockholder return against all companies in the NASDAQ Telecommunications Index at the end of a three-year performance period. Depending on the relative total stockholder return over the performance period, the recipient may earn from 0% to 150% of the shares underlying the PSUs, with the shares earned distributed upon the vesting. The fair value of the award is based on the market price of our common stock on the date of grant, adjusted for the expected outcome of the impact of market conditions using a Monte Carlo Simulation valuation method. A portion of the granted PSUs vests and the underlying shares become deliverable upon the death or disability of the recipient or upon a change of control of Adtran, as defined by the 2020 Employee Plan. The recipients of the PSUs receive dividend credits based on the shares of common stock underlying the PSUs. The dividend credits vest and are earned in the same manner as the PSUs and are paid in cash upon the issuance of common stock for the PSUs.
The fair value of RSUs and restricted stock is equal to the closing price of our stock on the grant date. RSUs and restricted stock vest ratably over four-year and one-year periods, respectively.
We will continue to assess the assumptions and methodologies used to calculate the estimated fair value of stock-based compensation. If circumstances change, and additional data becomes available over time, we may change our assumptions and methodologies, which may materially impact our fair value determination.
As of December 31, 2025, total unrecognized compensation expense related to the non-vested portion of market-based PSUs, RSUs and restricted stock was approximately $13.1 million, which is expected to be recognized over an average remaining recognition period of 2.4 years. Unrecognized compensation expense will be adjusted for actual forfeitures as they occur.
Stock Options
The following table summarizes the activity related to our stock options for the year ended December 31, 2025:
|
|
Number of |
|
|
Weighted |
|
|
Weighted Average |
|
|
Aggregate |
|
||||
Stock options outstanding, December 31, 2024 |
|
|
2,944 |
|
|
$ |
9.86 |
|
|
|
4.98 |
|
|
$ |
3,762 |
|
Stock options exercised |
|
|
(273 |
) |
|
$ |
6.70 |
|
|
|
|
|
|
|
||
Stock options forfeited |
|
|
(233 |
) |
|
$ |
14.65 |
|
|
|
|
|
|
|
||
Stock options expired |
|
|
(426 |
) |
|
$ |
14.01 |
|
|
|
|
|
|
|
||
Stock options outstanding, December 31, 2025 |
|
|
2,012 |
|
|
$ |
8.86 |
|
|
|
4.81 |
|
|
$ |
3,559 |
|
Stock options exercisable, December 31, 2025 |
|
|
1,828 |
|
|
$ |
7.83 |
|
|
|
4.95 |
|
|
$ |
3,559 |
|
As of December 31, 2025, there was $0.1 million of unrecognized compensation expense related to stock options which will be recognized over the remaining weighted-average period of 0.4 years. No stock options were granted during 2025.
The determination of the fair value of stock options was estimated using the Monte Carlo method and is affected by the historical volatility of its stock price, as well as assumptions regarding a number of complex and subjective variables that may have a significant impact on the fair value estimate. The stock option pricing model requires the use of several assumptions that impact the fair value estimate. These variables include, but are not limited to, the volatility of the Company's stock price and employee exercise behaviors.
All of the options were previously issued at exercise prices that approximated fair market value at the date of grant.
The aggregate intrinsic value of stock options represents the total pre-tax intrinsic value (the difference between the Company's closing stock price on the last trading day of the quarter and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2025. The amount of aggregate intrinsic value was $3.6 million as of December 31, 2025, which will change based on the fair market value of the Company's stock. The total pre-tax intrinsic value of options exercised during the years ended December 31, 2025 and 2024 was $0.8 million and $0.3 million, respectively.
The following table further describes our stock options outstanding as of December 31, 2025:
|
|
Options Outstanding |
|
|
Options Exercisable |
|
||||||||||||||
Range of |
|
Options |
|
|
Weighted Average |
|
|
Weighted |
|
|
Options |
|
|
Weighted |
|
|||||
$5.23 – $5.23 |
|
|
959 |
|
|
|
7.83 |
|
|
$ |
5.23 |
|
|
|
959 |
|
|
$ |
5.23 |
|
$5.24 – $8.58 |
|
|
329 |
|
|
|
1.07 |
|
|
$ |
7.95 |
|
|
|
329 |
|
|
$ |
7.95 |
|
$8.59 – $12.17 |
|
|
496 |
|
|
|
2.02 |
|
|
$ |
12.10 |
|
|
|
496 |
|
|
$ |
12.10 |
|
$12.18 – $19.08 |
|
|
228 |
|
|
|
3.27 |
|
|
$ |
18.34 |
|
|
|
44 |
|
|
$ |
15.31 |
|
|
|
|
2,012 |
|
|
|
|
|
|
|
|
|
1,828 |
|
|
|
|
|||
The Black-Scholes option pricing model (the “Black-Scholes Model”) is used to determine the estimated fair value of stock option awards on the date of grant. The Black-Scholes Model requires the input of certain assumptions that involve judgment. Because our stock options have characteristics significantly different from those of traded options, and because changes in the input assumptions can materially affect the fair value estimate, existing models may not provide reliable measures of fair value of our stock options. The stock option pricing model requires the use of several assumptions that impact the fair value estimate. These variables include, but are not limited to, the volatility of our stock price and employee exercise behaviors.
The stock option pricing model requires the use of several assumptions that impact the fair value estimate. These variables include, but are not limited to, the volatility of our stock price and employee exercise behaviors.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Mar 15, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Feb 25, 2022 | |
| 2020 | Feb 26, 2021 | |
| 2019 | Feb 25, 2020 | |
| 2018 | Feb 28, 2019 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.